Immunotherapy: A promising alternative

(Université catholique de Louvain) Since 2004, Sophie Lucas, a researcher at the UCLouvain de Duve Institute, has been studying the immune responses that cancer patients can develop against their own tumor. She is currently testing a new anti-cancer drug that would strengthen such immune responses. This research won the prestigious Belgian Academy of Medicine GSK Award, which recognizes work in the fields of vaccinology and immunology.